Manning Meredith
Chief Commercial Officer at SOLENO THERAPEUTICS INC
- Sold, on record
- $3.3M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Mar 27, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SOLENO THERAPEUTICS INCChief Commercial Officer
Sales by reason
0
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale SOLENO THERAPEUTICS INCUnusualMar 27 2025
Sold 45,249 shares at $67.28 ($3M)
Manning Meredith, Chief Commercial Officer
No 10b5-1 planSold 49.9% of holdings ($6.1M position)45,351 shares leftFirst sale on recordFiling
- 2 Form 4 sale SOLENO THERAPEUTICS INCNo planMar 27 +365 days
Sold 7,522 shares at $30.44 ($229k)
Manning Meredith, Chief Commercial Officer
No 10b5-1 planSold 10.4% of holdings ($2.2M position)64,507 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | SOLENO THERAPEUTICS INC | Chief Commercial Officer | Form 4 sale | 7,522 | $229k | 10.4% | No plan | SEC |
| Mar 27, 2025 | SOLENO THERAPEUTICS INC | Chief Commercial Officer | Form 4 sale | 45,249 | $3M | 49.9% | Unusual | SEC |